Why the study?
Atherosclerotic cardiovascular disease management faces challenges, including practice gaps in patient-provider decision making, coexisting cardiometabolic risk factors, and provider burnout, necessitating multidisciplinary and person-centred approaches.
A transformative shift toward person-centred care, integrating multidisciplinary and technological approaches, is essential for effective ASCVD management.
Answers are grounded in this paper and cite their sources.
Supports multi-level person-centred ASCVD care; leaves open need for prospective trials before practice change.
This article discusses the complex approach to managing atherosclerotic cardiovascular disease (ASCVD), focusing on person-centred care (PCC) to align treatment strategies with individual patient narratives, values, and preferences. It identifies significant challenges in management of ASCVD, such as the necessity for multidisciplinary strategies and the need for enhanced patient care, particularly given the coexistence of ASCVD with other cardiometabolic risk factors. The paper points out existing practice gaps, including limited patient-provider information sharing and decision making, and considers the role of technology in personalizing care and improving outcomes. Strategies such as electronic health records, telehealth platforms, and motivational interviewing are examined for their potential to boost patient engagement and adherence to treatment. In addition, the article discusses systemic issues such as health care provider burnout and the importance of creating customized care plans for patients with multiple health conditions. The integration of varied approaches, including the involvement of community pharmacists and health coaches, is suggested as important for effective management of ASCVD. This review highlights the need for an innovative, holistic strategy for management of ASCVD and advocates for a transformative shift toward PCC that integrates individual, community, and system-level interventions to enhance patient engagement, therapy adherence, and overall outcomes.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: